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The size, location and extent of fluid distribution, perieerdial wall thickness
and intraperieardlal abnormalities Couldbe delineated using anyplane echo. ‘
Loeulatad PE volume could be determined in all 8 pts. The pericardial wall
thickness eouid be measured and correlated well with the surgieel specimen
in 2 pts. The epicardial surface morphology, dynamic cardiac motion and
pathology Couldbe viaualizad in patients with moderately to large amount of
PE. The extent of Cardiaccompression could be assessed. Conclusion: 3DE
provides additional diagnostic information in assessing the spatial orienta-
tion of PD and could beviaualized the epicardiac motion and intra-pericardial
pathology in effusive pts.
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Constrictive Pericerditis
G. Holmvang, R.E. Dinsmore. Maasschusetts General Hospital, Boston,
MA, USA, Boston Heart Foundation, Cambridge, MA, USA
Magnetic Resonance Imaging (MRI) is offen helpful for establishing the
diagnosis of conatrietive perieerditis in patients with constricfiveh’estrietive
hemodynamic findings, by demonstrating abnormal pericardial thickening.
However, constriction may exist in the presence of only mild pericardial
thickening (c4 mm), and mild thickening can be difficult to differentiate from
a minor increase in perieardial fluid. MRI tharefore remains equivocal in some
0ss0s.
To help identify abnormal perieerdial function, a simple MR imaging
scheme was implemented in which magnetic tag lines (slices orthogonal
to the desired imaging plane) are prescribed graphically at right angles to the
perieardial surface and depositad at end-diastole. Normal pericerdial slid-
ing motion appears as a break in the tag line at the pericardial interfaca in
late aystolic images. Perieerdial adheaion is identified by absence of such
discontinuity in spite of deformation of the tag across the myocardium.
The above imaging protocol wee applied in 23 consecutive patients eval-
uated for possible constrictive pericarcfitis.Adhesion of pericardial surfacas
was identified in all 10 patients who had a final diagnosis of constriction, and
the distribution of adhesions was verified intraoperatively in 8 patients who
underwent periesrdieetomy. However, extensive adhesion was aleo found in
two patients who did not have constriction, including on ra-imaging following
perioardieotomy.
Weconcludethat MRI tagging allows identification of the perieerdialadhe-
sion associated with constriction, and is a helpful new tool for demonstrating
abnormal function where morphological changes may be mild, However,
confirmation of constriction alao requires that constrictive physiology must
be demonstrated. The method can beimplementad on a commercial scanner
without need for apeoialized pulse sequences.
D907165 Calcific Constrictive Pericarditis: A PassePhenomenon?
L.H. Ling, J.K. Oh, J.F. Breen, J.B. Seward, A.J. Tajik. Mayo C/inicand
Mayo Foundation, Rochestefi MN, USA
With the declina in tuberculosis, calcific constrictive pericarditis (CCP) is be-
Iievedtobe uncommon in the United States. We reviewed a 10-yrexparience
of 135 patients with surgically proven constrictive periearditis to determine
the incidence of CCP and its cliniesi correlates in the current era. Pericardial
calcification was present on chest x-ray in Mpts (25%, group i) and absent
in 101 oases (group H).
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Conclusions: 1) Perioardial calcification on chest x-ray is still raiatively
common, and remaina an important clue to the diagnoais of constriction,
2) CCP ia positively correlated with diseasa chronicity, a perioerdial knock,
atrial enlargement and atrial amhythmias, 3) The etiology of CCP is usuaily
indeterminate, even after an exhaustive saareh for tuberculoua and fungal
dieease.
[907-1661 Recurrent pericarditisand Colchicine:10-Yeareof
Experience
Y.Adler, J, Guindo, A. Rodriguez, Y, Shoenfeld, M. Ravid, M. de-Miguel,
M. Subirana, J. Shemesh, Y. Finkelstein, T. Bayes, J. Amir, G. Zandman,
D. Martinez, P.Langevitz, D. Zemer, M. Ehrenfeld, N. Krivoy, S. Sclarowaky,
A. Bay6s-de-Luna. Rabin Medical Centec Israel, Hospital de Sant Pau,
Barcelona, Spain
Recurrence is one of the major complications of pericarditia. Its treatment is
often difficult and corticosteroids, immunosupressive drugs or surgery may
be necessary. We conducted an international, multicenter study of patients
(pts) with recurrent pericarditis treated with colchicine (C). We included 41
pts (27 men; mean age 38.9 + 17.8 years). Pericarditis was idiopathic
in 28 pts and secondaty in 13. Before C pts received aspirin or NSAID
(n = 37), cortocoids (n = 27) and paricardiocentesis (n = 7) and a total
of 155 recurrences were noted (mean 3.7 & 2.8) with a median interval
between crises of 2.0 months (range 0.5-19). Pts were treatad with C (0.5-2
m@day)with a median duration of 13 months (range 3-128). For stetietieal
analysis, we mnducted a paired comparison design (Student’s t teat). During
the 939 months of C treatment only 8/41 pts presented new recurrences
(14.6%). C was dismntinued in 31 pte and a new relapae occurred in 13
eaaes (41.9%). Recurrences were generally minor and effectively controlled
with the reinitiation of C or adjuating its dosis. During a tofei follow-up of
2021 months 23/41 pts (56.1%) did not experienced new recurrences. The
differences between the symptom-free periods before and after treatment
with C (3.2 * 2.8 vs 47.9 + 35.2 months) are statistically significant (p c
0.0001). Cone/usiorr:Colchicine is an effectivaand safe drug forthe long-term
prevention of pericarditis.
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Nstriuretic Peptide Activities on Cardiorensl and
Neurohumorel fectors in Heart Fsilure
D. Fukai, A. Wada, T. Tsutamoto, Y. Maeda, M. Ohnishi, M. Kinoshita. Shiga
Univeraify of Medica/ Science, Otsu, Japan
The changes that defects in natriuretic peptides (NPs) can provoke in hemo-
dynamic, renal and neurohumoral factors in a pathological condition such as
heart failure (HF) have not been reported. To examine the effects of long-
term inhibition of NPsaetivities, we administrated an antagonist forguanylate
cyclase coupled NP receptors, HS-142-1 (HS), for 24 hours (1 mg/kg/hr) to
anesthetized dogs with early-stage HF induced by rapid ventricular pacing
(270 ppm, 8 days). In this experimentally produced HF, plasma ANP levels
were significantly increased from 51 to 240 (p < 0.01), but the plasma renin
activity (PRA) and plasma aldosterone levels were not higher than those in
the normal controls (4.15 vs 5.04, 70 vs 82, respectively, N.S).
HS (n = 5) Vehicle (n= 5)
Baseline 4 hrs 24 hrs Baseline 4 hra 24 hra
ANP (pg/ml) 240 314++ 3os# 256 238 242
Plasma cGMP 33.s 13.0” 12.2* 35.0 24,0 37.0
(pmolJml)
MAP (mmHg) 111,0 114.5 116.0 109.6 110.0 10s.5
PCWP (mmHg) 13.3 15.4# 16,24 13.4 13.7 13.4
U-V (m!fhr) 24.2 11.9$ 20.3t 20.3 19.4 19.7
PRA (ng/ml/hr) 5.04 7.36# 4.66t 5.28 5,73 4.31
Aldoaterone(pg/ml) 82 450# 260%t 143 114 114
‘P <0.05, *P <0.01 vs Baseline, tP <0.05 vs 4 hours,MAP; mean arterial pressure,
PCWP; pulmonarycapillaIywedge preaaure, U-V; urineflow rate.
HS significantly suppressed plasma cGMP ievels throughout the exper-
iment. PCWP but not MAP was elevated for 24 hours continuously. U-V
decreased, and PRA and plasma aldosterone ievel increased only aftar
4 hours of HS infusion. Unexpectedly, these parameters tended to return
to baseline values after 24 hours of infusion. EndWenqus NPs regulated
vascular tone and urine excretion, and suppressed the activation of the
renin-angiotensin system in the early-stage HF, before apparent elevation of
PRA and plasma aldosterone. However, long-term inhibition of NPs did not
cause the progressive exacerbation of volume retention or the activation of
the ranin-angiotensin system in dogs with HF.
